Status | Study |
Not yet recruiting |
Study Name: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2017-01-31 Interventions: Drug: GSK2330811 GSK2330811 wi |
Recruiting |
Study Name: Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis Condition: Systemic Sclerosis Date: 2016-09-30 Interventions: Drug: SAR156597 (ACT14604) Pha |
Recruiting |
Study Name: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension Condition: Scleroderma, Diffuse Scleroderma, Systemic Scleroderma, Li Date: 2016-02-08 Interventions: Drug: Oral Ifetroban Subjects |
Withdrawn |
Study Name: A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) Condition: Scleroderma Date: 2015-10-26 Interventions: Drug: BMS-986020 Other: Placebo |
Recruiting |
Study Name: Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis Condition: Scleroderma, Diffuse Diffuse Cutaneous Systemic Sclerosis Date: 2015-06-30 Interventions: Drug: IVA337 Capsules of 200mg |
Active, not recruiting |
Study Name: Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis Condition: Diffuse Cutaneous Systemic Sclerosis Date: 2015-06-04 Interventions: Drug: JBT-101 JBT-101 5 mg q a |
Recruiting |
Study Name: Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma Condition: Scleroderma Date: 2015-01-26 Interventions: Drug: atorvastatin Atorvastati |
Completed |
Study Name: Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis Condition: Early Diffuse Cutaneous Systemic Sclerosis Date: 2014-12-22 Interventions: Drug: Methotrexate Immunosuppr |
Active, not recruiting |
Study Name: Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2014-11-03 Interventions: Drug: Riociguat (Adempas, BAY63-2521) |
Recruiting |
Study Name: Autologous SCT for Progressive Systemic Sclerosis: a Prospective NIS Study Condition: Autoimmune Diseases Date: 2014-09-26 Interventions: Procedure: Autologous HSCT 1st AHSCT |